Phase I trial of CBLB 612 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2015
Price : $35 *
At a glance
- Drugs CBLB 612 (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions; First in man
- 13 Jul 2015 Results published in Cleveland BioLabs Media Release.
- 06 May 2015 Status changed from active, no longer recruiting to completed according to a Cleveland BioLabs media release.
- 16 Mar 2015 According to a Cleveland BioLabs media release, data from this trial are expected to be reported in second quarter of 2015.